Companion Animal Oncology - Medical Oncology II
Course content
The purpose of this course is to provide experience and expertise in the medical and multimodality management of companion animal cancer patients including indications for, planning of, and administration of single and multiagent chemotherapy for the most commonly treated companion animal cancers and the principles and role of radiotherapy. The mechanism of action, principles of use of cytostatic drugs as well as the administration as either single agent or multi-agent protocols or as part of multimodality approaches in the treatment of the most common companion animal cancers will be part of this module.
Furthermore classification, monitoring, prevention, and management of chemotherapy adverse effects according to the guidelines established by VCOG (Veterinary Comparative Oncology Group).
Each participant makes procedures for the treatment protocols used to treat the most common companion animal medical oncology patients for their own practice.
This course is a specialisation course at the Master of Companion Animal Clinical Science. The master is a post graduate education targeted small animal veterinarians seeking Continual Professional Development (CPD).
Read more about the Master of Companion Animal Clinical Science.
Having completed the course, the student shall be able to:
Knowledge
• Describe and reflect on common ethical, safety, and
environmental considerations in treatment with cytostatic drugs in
companion animal cancer patients.
• Define, identify, and demonstrate overview of commonly used
companion animal cancer chemotherapy protocols and multimodality
approaches to therapeutic management.
• List, classify, and demonstrate critical reflection on
existing and new medical or combined approaches to oncology patient
therapy and client education.
• Demonstrate appropriate understanding regarding nutrition,
nutraceuticals, and supplementary therapies in veterinary cancer
patients.
• Be current on specific blood product transfusion guidelines
and demonstrate an understanding of hemostatic disorders in
veterinary cancer patients.
• Have an in-depth knowledge of cancer-related pain.
• Understand the use of radiotherapy in veterinary cancer
patients.
Skills
• Use appropriate procedures and administration protocols for
medical management and follow-up of specific companion animal
cancer types.
• Interpret, assess, and reflect on stage and grade of cancer
in relation to the planning of the therapeutic approach incl. which
modalities, protocol, and the administration of chemotherapy in
individual patients.
• Plan, apply, and integrate new evidence-based scientific
approaches to plan and administer medical therapy in companion
animal cancer patients, pain management, nutritional management,
and other supportive therapy.
• Detect, assess, and address adverse effects of cancer
chemotherapy effectively and in a timely fashion.
• Communicate effectively in writing and pass on therapeutic
results to relevant parties.
Competences
• Evaluate and manage the medical therapy of companion animal
cancer patients which may necessitate novel solutions and
approaches identified from current medical literature or other
resources as they pertain to the individual patient.
• Work independently, take responsibility for, predict, and
prognosticate based on response to therapy for commonly medically
treated companion animal cancers.
• Collaborate constructively within and between
specialists/professionals and lay persons involved in companion
animal medical cancer treatment.
• Independently evaluate and structure own learning processes
and continuously obtain new knowledge within the medical management
of companion animal cancer patients.
Lectures, Theoretical and practical exercises. Case studies.
Updated literature list will be posted 1 month prior to course start. The participant should have theoretical knowledge updated prior to participation.
Inclusion criteria for Master's Programme in Companion
Animal Clinical Science: Degree in veterinary medicine and at least
two years of relevant work experience.
SCAM13001U, SCAM13002U, SCAM13003U, SCAM13004U or one of the
following certifications in Companion Animal Diseases:
• Danish Certificate in Small Animal Diseases, in danish known as
"Fagdyrlæge i sygdomme hos hunde og katte".
• Swedish Specialist in Diseases of Dogs and Cats, in Swedish known
as "Steg 1".
• Norwegian Specialist in Diseases of Dogs and Cats, in Norwegian
known as "Specialisering i veterinærmedisin, spesialitet
smådyr".
• Finnish Specialist in Diseases of Dogs and Cats, in Finnish known
as “Pieneläinsairauksien erikoiseläinlääkäri".
- ECTS
- 1 ECTS
- Type of assessment
-
Other
- Type of assessment details
- The Ongoing Exam consists of three parts:
a) a minimum of 80% active participation,
b) preparation and oral presentation of a problem-oriented clinical case,
c) a written assignment: Evidence-based procedure.
To pass the course, students must have passed Exam 1 and Exam 2. However, students may attend Exam 2 without having passed Exam 1. - Aid
- All aids allowed except Generative AI
- Marking scale
- passed/not passed
- Censorship form
- No external censorship
- Exam period
-
For information about the exact exam dates, please visit the exam schedule.
- Re-exam
-
For information about the exact exam dates, please visit the exam schedule.
Criteria for exam assessment
To achieve the grade passed, the student shall be able to:
Knowledge
• Describe and reflect on common ethical, safety, and
environmental considerations in treatment with cytostatic drugs in
companion animal cancer patients.
• Define, identify, and demonstrate overview of commonly used
companion animal cancer chemotherapy protocols and multimodality
approaches to therapeutic management.
• List, classify, and demonstrate critical reflection on
existing and new medical or combined approaches to oncology patient
therapy and client education.
• Demonstrate appropriate understanding regarding nutrition,
nutraceuticals, and supplementary therapies in veterinary cancer
patients.
• Be current on specific blood product transfusion guidelines
and demonstrate an understanding of hemostatic disorders in
veterinary cancer patients.
• Have an in-depth knowledge of cancer-related pain.
• Understand the use of radiotherapy in veterinary cancer
patients.
Skills
• Use appropriate procedures and administration protocols for
medical management and follow-up of specific companion animal
cancer types.
• Interpret, assess, and reflect on stage and grade of cancer
in relation to the planning of the therapeutic approach incl. which
modalities, protocol, and the administration of chemotherapy in
individual patients.
• Plan, apply, and integrate new evidence-based scientific
approaches to plan and administer medical therapy in companion
animal cancer patients, pain management, nutritional management,
and other supportive therapy.
• Detect, assess, and address adverse effects of cancer
chemotherapy effectively and in a timely fashion.
• Communicate effectively in writing and pass on therapeutic
results to relevant parties.
Competences
• Evaluate and manage the medical therapy of companion animal
cancer patients which may necessitate novel solutions and
approaches identified from current medical literature or other
resources as they pertain to the individual patient.
• Work independently, take responsibility for, predict, and
prognosticate based on response to therapy for commonly medically
treated companion animal cancers.
• Collaborate constructively within and between
specialists/professionals and lay persons involved in companion
animal medical cancer treatment.
• Independently evaluate and structure own learning processes
and continuously obtain new knowledge within the medical management
of companion animal cancer patients.
- ECTS
- 5 ECTS
- Type of assessment
-
Written assignment
- Type of assessment details
- The written assignment includes an exam with multiple-choice, short answer, and/or essay questions.
- Examination prerequisites
-
Students may attend this examination without approval of Exam 1 (SCAM25041E Ongoing Test).
- Aid
- All aids allowed except Generative AI
- Marking scale
- 7-point grading scale
- Censorship form
- External censorship
- Exam period
-
For information about the exact exam dates, please visit the exam schedule.
- Re-exam
-
For information about the exact exam dates, please visit the exam schedule.
Criteria for exam assessment
To achieve the maximum grade 12, the student shall be
able to:
Knowledge
• Describe and reflect on common ethical, safety, and
environmental considerations in treatment with cytostatic drugs in
companion animal cancer patients.
• Define, identify, and demonstrate overview of commonly used
companion animal cancer chemotherapy protocols and multimodality
approaches to therapeutic management.
• List, classify, and demonstrate critical reflection on
existing and new medical or combined approaches to oncology patient
therapy and client education
• Demonstrate appropriate understanding regarding nutrition,
nutraceuticals, and supplementary therapies in veterinary cancer
patients.
• Be current on specific blood product transfusion guidelines
and demonstrate an understanding of hemostatic disorders in
veterinary cancer patients.
• Have an in-depth knowledge of cancer-related pain
• Understand the use of radiotherapy in veterinary cancer
patients.
Skills
• Use appropriate procedures and administration protocols for
medical management and follow-up of specific companion animal
cancer types.
• Interpret, assess, and reflect on stage and grade of cancer
in relation to the planning of the therapeutic approach incl. which
modalities, protocol, and the administration of chemotherapy in
individual patients.
• Plan, apply, and integrate new evidence-based scientific
approaches to plan and administer medical therapy in companion
animal cancer patients, pain management, nutritional management,
and other supportive therapy.
• Detect, assess, and address adverse effects of cancer
chemotherapy effectively and in a timely fashion.
• Communicate effectively in writing and pass on therapeutic
results to relevant parties.
Competences
• Evaluate and manage the medical therapy of companion animal
cancer patients which may necessitate novel solutions and
approaches identified from current medical literature or other
resources as they pertain to the individual patient.
• Work independently, take responsibility for, predict, and
prognosticate based on response to therapy for commonly medically
treated companion animal cancers.
Part time Master and Diploma courses
- Category
- Hours
- Lectures
- 10
- Preparation
- 72
- Theory exercises
- 30
- Exam
- 50
- English
- 162
Kursusinformation
- Language
- English
- Course number
- SCAM25041U
- ECTS
- See exam description
- Programme level
- Part Time Master
- Duration
-
5 course days full time.
- Placement
- Spring
This course is offered in the Spring semester (even-numbered years). For more information about the exact course dates, please visit the webpage.
- Price
- Schedulegroup
-
Monday - Friday full time.
- Capacity
- 12
- Studyboard
- Study Board for the Professionel Master´s Degree Programmes at The Faculty og Health and Medical Science
Contracting department
- Department of Veterinary Clinical Sciences
Contracting faculty
- Faculty of Health and Medical Sciences
Course Coordinator
- Maja Louise Arendt (11-796d766d3a6d7e717a70804c7f817a703a77813a7077)
Teacher
National and International capacities within the fields.
Er du BA- eller KA-studerende?
Kursusinformation for indskrevne studerende